John Celebi - Feb 15, 2023 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
President and CEO, Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
SNSE
Transactions as of
Feb 15, 2023
Transactions value $
-$30,738
Form type
4
Date filed
9/11/2023, 05:33 PM
Previous filing
Feb 17, 2022
Next filing
Sep 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Tax liability -$30.7K -20.5K -15.61% $1.50 111K Feb 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.